TAVANIC

This brand name is authorized in Nigeria. It is also authorized in Austria, Cyprus, Estonia, Finland, France, Germany, Ireland, Israel, Italy, Lithuania, Malta, Mexico, Netherlands, Poland, Romania, South Africa, Spain, Tunisia, Turkey.

Active ingredients

The drug TAVANIC contains one active pharmaceutical ingredient (API):

1	Levofloxacin hemihydrate UNII 6GNT3Y5LMF - LEVOFLOXACIN
	Levofloxacin is a synthetic antibacterial agent of the fluoroquinolone class. As a fluoroquinolone antibacterial agent, levofloxacin acts on the DNA – DNA-gyrase complex and topoisomerase IV.
	Read more about Levofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-3143	Tablet	Tavanic Tablets TAB 500 mg	Each tablet contains: Levofloxacin Hemihydrate equiv. to Levofloxacin 500 mg	21/12/2020
04-5409	Solution for infusion	Tavanic 5 mg/mL Solution for Infusion INJ_SOL 500 mg/100 mL	Solution for Infusion Each mL contains: Levofloxacin 5 mg (500 mg/100 mL)	26/08/2021

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
TAVANIC Film-coated tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA12	Levofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	08586241, 08586264, 08586270, 08752627
EE	Ravimiamet	1102723, 1102734, 1102745, 1102756, 1102767, 1102778, 1102789, 1102790, 1102802, 1102813, 1102824, 1102857, 1102868, 1141669, 1144583, 1144594, 1144606, 1295681, 1295759, 1736636
ES	Centro de información online de medicamentos de la AEMPS	62065
FI	Lääkealan turvallisuus- ja kehittämiskeskus	076950, 375259, 510564
FR	Base de données publique des médicaments	64784789, 69091027
IE	Health Products Regulatory Authority	56911, 56938, 56965
IL	מִשְׂרַד הַבְּרִיאוּת	4191
IT	Agenzia del Farmaco	033634015, 033634039
LT	Valstybinė vaistų kontrolės tarnyba	1009238, 1009239, 1009240, 1009242, 1009243, 1009244, 1009245, 1009246, 1009247, 1068231, 1068232, 1068233, 1068234, 1068235, 1068236, 1068237, 1068238, 1068239, 1068240, 1068241
MT	Medicines Authority	MA1359/03801, PI908/07801A
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	391M97, 392M97
NG	Registered Drug Product Database	04-3143, 04-5409
NL	Z-Index G-Standaard, PRK	97500
PL	Rejestru Produktów Leczniczych	100101867
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W55699001, W55699002, W55699003, W55699004, W55700001, W55700002, W55700003, W55701001, W55702001
TN	Direction de la Pharmacie et du Médicament	5363041H, 9263141, 9263142
TR	İlaç ve Tıbbi Cihaz Kurumu	8699809097667, 8699809690233
ZA	Health Products Regulatory Authority	32/20.1.1/0123, 32/20.1.1/0124, 32/20.1.1/0125, 34/20.1.1/0002, 43/20.1.1/0947, 43/20.1.1/0948